State laws designed to ensure that the pill form of cancer drugs is not more costly than treatments given through an infusion in a clinic or hospital have had a mixed impact on patients’ pocketbooks, according to University of North … Read more

A study by researchers at the UNC Eshelman School of Pharmacy and Lineberger Comprehensive Cancer Center determined the cost savings for a generic version of an orally administered cancer treatment were less than expected — a finding that questions the … Read more

Physicians paid by pharmaceutical companies for meals, talks and travel had higher odds of prescribing those companies’ drugs to treat two cancer types, a University of North Carolina at Chapel Hill study has found. “Ideally, therapy choices should be based … Read more

Stacie Dusetzina, Ph.D., has been confirmed as a committee member for the National Academies of Sciences, Engineering and Medicine report titled “Ensuring Patient Access to Affordable Drug Therapies.” The committee is charged by the National Academy of Medicine (formerly the … Read more

The significant out-of-pocket costs that cancer patients can face before Medicare drug benefits kick in may delay the patients’ treatment with a new class of highly effective therapies, according to a University of North Carolina study. In the study published … Read more

Nearly 9 out of 10 physicians and researchers who helped develop a leading set of cancer-care guidelines in the United States reported financial ties to the pharmaceutical and medical device industries, a University of North Carolina at Chapel Hill study … Read more

Specialty drugs are a relatively small part of total prescriptions filled at the pharmacy, but they are a dramatically increasing part of total prescription spending. A new study from the University of North Carolina at Chapel Hill reveals that just … Read more

For advanced liver cancer, there’s a single approved drug shown to offer patients a chance at longer life. But a new study by University of North Carolina at Chapel Hill researchers found that this drug was notably less effective in … Read more

New cancer drugs taken in pill form have become dramatically more expensive in their first year on the market compared with drugs launched 15 years ago, a University of North Carolina at Chapel Hill study has found. The findings call … Read more

The advent of targeted drugs for a specific type of breast cancer – HER2 positive – has dramatically improved survival rates for women with the disease. But a study led by researchers at the University of North Carolina at Chapel … Read more